Audiovestibular Disorders after COVID-19 Vaccine: Is There an Association?

• Published in: Audiology research (Pavia, Italy) Italy), 2022-04, Vol.12 (3), p.212-223
• Main Authors: Pisani, Davide, Gioacchini, Federico Maria, Viola, Pasquale, Scarpa, Alfonso, Astorina, Alessia, Re, Massimo, Marcianò, Gianmarco, Manti, Francesco, Anzivino, Roberta, Chiarella, Giuseppe
• Format: Article
• Language: English
• Subjects: adverse event; Coronaviruses; COVID-19; COVID-19 vaccines; Drug dosages; Hearing loss; Magnetic resonance imaging; Pandemics; Patients; Proteins; Review; Severe acute respiratory syndrome coronavirus 2; SSNHL; Tinnitus; vaccine; Vectors (Biology); Vertigo
• ISSN: 2039-4349; 2039-4330; 2039-4349
• DOI: 10.3390/audiolres12030024

The SARS-CoV-2 vaccination campaign is probably one of the most historic public hygiene measures in modern medicine. The drama of the pandemic has forced the scientific community to accelerate the development and commercialization of vaccines, thereby enhancing the phases of active surveillance. Among the adverse events following immunization (AEFI) reported, those of an audiovestibular interest, such as sudden sensorineural hearing loss (SSNHL), tinnitus, dizziness, and vertigo, constitute a very small percentage. There are many plausible etiological hypotheses, and scientific research needs to pay more attention to the correct collection of data, which up until now have often been inadequate and fragmented, on which to base future studies. SSNHL, new onset tinnitus, vertigo, and dizziness require a prompt evaluation, while the proposed treatment is the same as it is for events unrelated to vaccination. These are uncommon adverse events, and the risk rates for these diseases have not increased in conjunction with the COVID-19 vaccinations, therefore there is no justification of any hesitation towards the vaccination campaign.